Hibernia Wealth Partners’s AbbVie ABBV Stock Holding History

Hibernia Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,874	Closed	-$407K	–	83
2026 Q1	$407K	Sell	1,874 -485	-21%	-$108K	0.12%	71
2025 Q4	$539K	Buy	+2,359	New	+$537K	0.16%	50
2025 Q3	–	Sell	-2,157	Closed	-$400K	–	50
2025 Q2	$400K	Buy	+2,157	New	+$401K	0.13%	55
2024 Q4	–	Sell	-1,718	Closed	-$339K	–	55
2024 Q3	$339K	Buy	1,718 +8	+0.5%	+$1.49K	0.1%	85
2024 Q2	$293K	Buy	+1,710	New	+$283K	0.1%	61
2023 Q4	–	Sell	-241	Closed	-$35.9K	–	67
2023 Q3	$35.9K	Buy	+241	New	+$35.4K	0.03%	102

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Hibernia Wealth Partners's ABBV Position: Q2 2026 in Review

Hibernia Wealth Partners sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,874 shares — an estimated $407K sold.

Hibernia Wealth Partners first reported a position in ABBV in Q3 2023 and held it in 6 quarters. The position peaked at $539K in Q4 2025. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hibernia Wealth Partners reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Hibernia Wealth Partners sold 1,874 AbbVie shares in Q2 2026, an estimated $407K.
Hibernia Wealth Partners first reported a position in AbbVie in Q3 2023 and held it in 6 quarters.
Hibernia Wealth Partners's AbbVie position peaked at $539K in Q4 2025.
1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hibernia Wealth Partners's 13F filing for Q2 2026, filed 23 Jul 2026.